Literature DB >> 6782207

Fibronectin.

E Ruoslahti.   

Abstract

The current knowledge of the structure, expression and functions and fibronectin is reviewed. Fibronectin is a high molecular glycoprotein present in the blood, connective tissue and at cell surface. It is synthesized by many types of differentiated cells and is believed to be involved in the attachment of cells to the surrounding extracellular matrix. Fibronectin has affinity to the other main components of extracellular matrix, collagen and glycosaminoglycans. It also interacts with cell surfaces as shown by the fact that fibronectin-collagen complexes, or fibronectin alone when insolubilized on a surface such as plastic, enhances the attachment of various types of cells to such surfaces. It seems that fibronectin, through its binding to collagen and to the cell surface, forms a bridge between the cell and its surrounding matrix. Circulating fibronectin may participate in the formation of extracellular matrix in tissues. It may also function as a nonspecific opsonin design to facilitate the uptake of tissue debris by phagocytic cells. Studies aimed at elucidating the significance of fibronectin in physiological phenomena and in disease have only just begun. The abundance of fibronectin in basement membrane structures and the development changes observed in its expression lead one to believe that the attachment (or lack of it) of cells to fibronectin plays a significant role in morphogenetic events or in normal development. Malignantly transformed cells tend to lack cell-associated fibronectin. The significance of the lack of surface fibronectin in transformed cells is a matter of some controversy, but it fibronectin is indeed the main mechanism that anchors cells to the extracellular matrix, disturbances of this mechanism could play an important role in malignancy and many other diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782207     DOI: 10.1111/j.1600-0714.1981.tb01242.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  10 in total

1.  Repair in arterial tissue. Demonstration of fibronectin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique.

Authors:  J Chemnitz; B Collatz Christensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

2.  Injury and repair of smaller muscular and elastic arteries. Immunohistochemical demonstration of fibronectin and fibrinogen/fibrin and their degradation products in rabbit femoral and common carotid arteries following a dilatation injury.

Authors:  L H Rasmussen; C Garbarsch; J Chemnitz; B C Christensen; I Lorenzen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.

Authors:  Siddharth P Pathi; Debra D W Lin; Jason R Dorvee; Lara A Estroff; Claudia Fischbach
Journal:  Biomaterials       Date:  2011-04-20       Impact factor: 12.479

4.  Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins.

Authors:  Corban G Rivera; Joel S Bader; Aleksander S Popel
Journal:  Ann Biomed Eng       Date:  2011-05-18       Impact factor: 3.934

5.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

6.  Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin.

Authors:  H S Courtney; W A Simpson; E H Beachey
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

7.  Binding of fibronectin to human buccal epithelial cells inhibits the binding of type 1 fimbriated Escherichia coli.

Authors:  W A Simpson; D L Hasty; E H Beachey
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Human plasma fibronectin inhibits adherence of Streptococcus pyogenes to hexadecane.

Authors:  H S Courtney; I Ofek; W A Simpson; E Whitnack; E H Beachey
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Comparative evaluation of human chorion membrane and platelet-rich fibrin membrane with coronally advanced flap in treatment of Miller's class I and II recession defects: A randomized controlled study.

Authors:  Shivani Ashwinikumar Dandekar; Neeraj Chandrahas Deshpande; Deepak Harishchandra Dave
Journal:  J Indian Soc Periodontol       Date:  2019 Mar-Apr

Review 10.  Extracellular Matrix and the Production of Cultured Meat.

Authors:  Khurshid Ahmad; Jeong-Ho Lim; Eun-Ju Lee; Hee-Jin Chun; Shahid Ali; Syed Sayeed Ahmad; Sibhghatulla Shaikh; Inho Choi
Journal:  Foods       Date:  2021-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.